| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Non-alcoholic Fatty Liver Disease | 9 | 2019 | 907 | 1.09 | Why? |
| MAP Kinase Kinase Kinases | 3 | 2018 | 48 | 0.96 | Why? |
| Atherosclerosis | 6 | 2018 | 768 | 0.87 | Why? |
| Hepatocytes | 4 | 2019 | 549 | 0.77 | Why? |
| Proto-Oncogene Proteins | 1 | 2018 | 340 | 0.60 | Why? |
| Insulin Resistance | 4 | 2018 | 669 | 0.56 | Why? |
| Benzaldehydes | 2 | 2011 | 27 | 0.53 | Why? |
| Macrophages | 5 | 2019 | 2784 | 0.49 | Why? |
| Mice, Knockout | 9 | 2019 | 1815 | 0.45 | Why? |
| Vanillic Acid | 1 | 2009 | 1 | 0.43 | Why? |
| Citrinin | 1 | 2009 | 2 | 0.43 | Why? |
| Naphthols | 1 | 2009 | 8 | 0.42 | Why? |
| Rhizophoraceae | 1 | 2009 | 5 | 0.42 | Why? |
| Fungi | 2 | 2011 | 471 | 0.39 | Why? |
| MAP Kinase Kinase Kinase 5 | 2 | 2017 | 16 | 0.35 | Why? |
| Inflammation | 5 | 2018 | 13255 | 0.34 | Why? |
| Interferon Regulatory Factors | 2 | 2019 | 141 | 0.34 | Why? |
| Diet, High-Fat | 5 | 2019 | 161 | 0.34 | Why? |
| Cardiomegaly | 2 | 2017 | 96 | 0.33 | Why? |
| DNA-Binding Proteins | 3 | 2019 | 469 | 0.33 | Why? |
| Apoptosis Regulatory Proteins | 2 | 2017 | 202 | 0.31 | Why? |
| MicroRNAs | 1 | 2018 | 1787 | 0.28 | Why? |
| Gene Expression Regulation | 4 | 2019 | 4020 | 0.28 | Why? |
| Haplorhini | 3 | 2018 | 307 | 0.25 | Why? |
| Liver | 6 | 2020 | 4007 | 0.24 | Why? |
| Mice | 16 | 2019 | 21357 | 0.24 | Why? |
| Apolipoproteins E | 3 | 2017 | 170 | 0.23 | Why? |
| Mice, Inbred C57BL | 8 | 2019 | 5542 | 0.22 | Why? |
| Mitogen-Activated Protein Kinase 8 | 2 | 2017 | 15 | 0.22 | Why? |
| Glycemic Index | 1 | 2020 | 115 | 0.19 | Why? |
| Acidosis | 1 | 2020 | 125 | 0.19 | Why? |
| Liver X Receptors | 1 | 2018 | 13 | 0.19 | Why? |
| MAP Kinase Kinase 7 | 1 | 2018 | 19 | 0.19 | Why? |
| LIM Domain Proteins | 1 | 2018 | 8 | 0.19 | Why? |
| Mitogen-Activated Protein Kinase Phosphatases | 1 | 2018 | 14 | 0.19 | Why? |
| Dual-Specificity Phosphatases | 1 | 2018 | 15 | 0.19 | Why? |
| JNK Mitogen-Activated Protein Kinases | 1 | 2018 | 59 | 0.18 | Why? |
| PPAR gamma | 1 | 2019 | 102 | 0.18 | Why? |
| Creatine Kinase, MB Form | 1 | 2020 | 259 | 0.18 | Why? |
| TNF Receptor-Associated Factor 6 | 1 | 2017 | 20 | 0.18 | Why? |
| Plaque, Atherosclerotic | 3 | 2018 | 423 | 0.18 | Why? |
| rac1 GTP-Binding Protein | 1 | 2017 | 32 | 0.18 | Why? |
| Multivesicular Bodies | 1 | 2017 | 10 | 0.18 | Why? |
| CASP8 and FADD-Like Apoptosis Regulating Protein | 1 | 2017 | 7 | 0.18 | Why? |
| Milk Proteins | 1 | 2017 | 47 | 0.18 | Why? |
| Extracellular Matrix Proteins | 1 | 2018 | 95 | 0.18 | Why? |
| Blotting, Western | 5 | 2018 | 863 | 0.17 | Why? |
| Angiotensin-Converting Enzyme Inhibitors | 3 | 2020 | 5277 | 0.17 | Why? |
| Neointima | 1 | 2017 | 39 | 0.17 | Why? |
| Deoxyribonucleases | 1 | 2016 | 34 | 0.17 | Why? |
| Muscle Proteins | 1 | 2017 | 64 | 0.17 | Why? |
| Poly-ADP-Ribose Binding Proteins | 1 | 2016 | 47 | 0.17 | Why? |
| Toll-Like Receptor 4 | 2 | 2017 | 390 | 0.17 | Why? |
| Muscle, Smooth, Vascular | 1 | 2017 | 86 | 0.17 | Why? |
| Neuropeptides | 1 | 2017 | 91 | 0.16 | Why? |
| Kruppel-Like Transcription Factors | 1 | 2017 | 91 | 0.16 | Why? |
| Antigens, Surface | 1 | 2017 | 181 | 0.16 | Why? |
| Adaptor Proteins, Signal Transducing | 2 | 2017 | 502 | 0.16 | Why? |
| Reperfusion Injury | 1 | 2017 | 178 | 0.15 | Why? |
| Up-Regulation | 3 | 2018 | 2249 | 0.15 | Why? |
| Transcription Factors | 2 | 2018 | 784 | 0.15 | Why? |
| Infarction, Middle Cerebral Artery | 1 | 2017 | 203 | 0.15 | Why? |
| Oxidation-Reduction | 1 | 2018 | 540 | 0.15 | Why? |
| Nerve Tissue Proteins | 1 | 2017 | 319 | 0.15 | Why? |
| Intercellular Signaling Peptides and Proteins | 1 | 2017 | 245 | 0.14 | Why? |
| Animals | 19 | 2019 | 78931 | 0.14 | Why? |
| Protein Processing, Post-Translational | 1 | 2017 | 634 | 0.14 | Why? |
| Interferon Regulatory Factor-3 | 1 | 2017 | 379 | 0.14 | Why? |
| Homeostasis | 1 | 2018 | 582 | 0.13 | Why? |
| Ventricular Remodeling | 1 | 2017 | 349 | 0.13 | Why? |
| Cell Adhesion Molecules | 1 | 2017 | 472 | 0.13 | Why? |
| Angiotensin Receptor Antagonists | 2 | 2020 | 3892 | 0.13 | Why? |
| Genetic Therapy | 1 | 2018 | 409 | 0.13 | Why? |
| Metformin | 1 | 2020 | 640 | 0.13 | Why? |
| Natriuretic Peptide, Brain | 1 | 2020 | 1215 | 0.12 | Why? |
| Drug Carriers | 1 | 2019 | 590 | 0.12 | Why? |
| RNA, Messenger | 2 | 2017 | 5131 | 0.12 | Why? |
| Hyperglycemia | 2 | 2021 | 1363 | 0.12 | Why? |
| Coronary Artery Disease | 2 | 2017 | 2570 | 0.12 | Why? |
| Troponin I | 1 | 2020 | 1298 | 0.11 | Why? |
| Benzopyrans | 1 | 2011 | 39 | 0.11 | Why? |
| Seaweed | 1 | 2011 | 36 | 0.11 | Why? |
| Diabetes Mellitus, Type 2 | 3 | 2021 | 6166 | 0.11 | Why? |
| Peptide Fragments | 1 | 2020 | 2075 | 0.10 | Why? |
| Coronary Vessels | 1 | 2017 | 914 | 0.10 | Why? |
| Carcinoma, Hepatocellular | 1 | 2019 | 1222 | 0.09 | Why? |
| Cysteine Endopeptidases | 1 | 2018 | 1557 | 0.09 | Why? |
| Signal Transduction | 7 | 2018 | 7207 | 0.09 | Why? |
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2020 | 1510 | 0.09 | Why? |
| Mice, Knockout, ApoE | 2 | 2018 | 42 | 0.09 | Why? |
| Blood Glucose | 2 | 2020 | 3642 | 0.09 | Why? |
| Endosomal Sorting Complexes Required for Transport | 2 | 2017 | 67 | 0.09 | Why? |
| Molecular Structure | 2 | 2011 | 1539 | 0.09 | Why? |
| Antihypertensive Agents | 1 | 2020 | 1962 | 0.09 | Why? |
| Lymphocytes | 1 | 2021 | 3056 | 0.09 | Why? |
| Liver Cirrhosis | 1 | 2019 | 1810 | 0.08 | Why? |
| Liver Neoplasms | 1 | 2019 | 1666 | 0.08 | Why? |
| Mice, Transgenic | 3 | 2019 | 2739 | 0.08 | Why? |
| Peptides | 1 | 2019 | 2513 | 0.08 | Why? |
| Membrane Proteins | 1 | 2017 | 1733 | 0.08 | Why? |
| p38 Mitogen-Activated Protein Kinases | 2 | 2018 | 230 | 0.08 | Why? |
| Ubiquitination | 2 | 2017 | 343 | 0.08 | Why? |
| Heart Failure | 2 | 2017 | 6638 | 0.08 | Why? |
| Chromatography, High Pressure Liquid | 1 | 2009 | 669 | 0.08 | Why? |
| Evidence-Based Medicine | 1 | 2019 | 3228 | 0.07 | Why? |
| Immunohistochemistry | 3 | 2018 | 2275 | 0.07 | Why? |
| Disease Models, Animal | 6 | 2019 | 10998 | 0.07 | Why? |
| Rats, Sprague-Dawley | 2 | 2017 | 987 | 0.07 | Why? |
| Lysosomes | 2 | 2017 | 416 | 0.07 | Why? |
| Fluorescent Antibody Technique | 2 | 2017 | 835 | 0.07 | Why? |
| Neutrophils | 1 | 2021 | 5476 | 0.07 | Why? |
| Adrenal Cortex Hormones | 1 | 2021 | 6537 | 0.06 | Why? |
| Heart Diseases | 1 | 2020 | 3503 | 0.06 | Why? |
| Macaca fascicularis | 2 | 2017 | 1009 | 0.06 | Why? |
| Down-Regulation | 2 | 2019 | 1416 | 0.06 | Why? |
| Cells, Cultured | 3 | 2017 | 5835 | 0.06 | Why? |
| Hypertension | 2 | 2020 | 8895 | 0.06 | Why? |
| Male | 15 | 2020 | 367725 | 0.06 | Why? |
| Positron-Emission Tomography | 2 | 2017 | 802 | 0.06 | Why? |
| Drug Repositioning | 1 | 2020 | 5683 | 0.06 | Why? |
| Acidosis, Lactic | 1 | 2020 | 83 | 0.05 | Why? |
| NF-kappa B | 2 | 2017 | 1301 | 0.05 | Why? |
| Rats | 2 | 2017 | 2764 | 0.05 | Why? |
| Pneumonia, Viral | 7 | 2020 | 243684 | 0.05 | Why? |
| Coronavirus Infections | 7 | 2020 | 253789 | 0.05 | Why? |
| Alkaline Phosphatase | 1 | 2020 | 257 | 0.05 | Why? |
| ATP Binding Cassette Transporter 1 | 1 | 2018 | 17 | 0.05 | Why? |
| Foam Cells | 1 | 2018 | 21 | 0.05 | Why? |
| Deubiquitinating Enzyme CYLD | 1 | 2018 | 9 | 0.05 | Why? |
| Biopsy | 2 | 2019 | 2811 | 0.05 | Why? |
| Humans | 26 | 2021 | 930598 | 0.05 | Why? |
| Angiotensins | 1 | 2020 | 259 | 0.05 | Why? |
| MAP Kinase Kinase 4 | 1 | 2018 | 36 | 0.05 | Why? |
| Mice, Nude | 1 | 2019 | 340 | 0.04 | Why? |
| Nedd4 Ubiquitin Protein Ligases | 1 | 2017 | 43 | 0.04 | Why? |
| Vinculin | 1 | 2017 | 3 | 0.04 | Why? |
| China | 5 | 2021 | 50654 | 0.04 | Why? |
| In Situ Nick-End Labeling | 1 | 2016 | 39 | 0.04 | Why? |
| Real-Time Polymerase Chain Reaction | 4 | 2018 | 11367 | 0.04 | Why? |
| Gene Knock-In Techniques | 1 | 2017 | 124 | 0.04 | Why? |
| Mitogen-Activated Protein Kinases | 1 | 2017 | 126 | 0.04 | Why? |
| Obesity | 1 | 2018 | 7388 | 0.04 | Why? |
| Bilirubin | 1 | 2020 | 503 | 0.04 | Why? |
| Elasticity Imaging Techniques | 1 | 2019 | 194 | 0.04 | Why? |
| beta Catenin | 1 | 2017 | 78 | 0.04 | Why? |
| Risk Assessment | 1 | 2021 | 25439 | 0.04 | Why? |
| RAW 264.7 Cells | 1 | 2017 | 316 | 0.04 | Why? |
| Cellular Reprogramming | 1 | 2017 | 117 | 0.04 | Why? |
| Random Allocation | 1 | 2019 | 773 | 0.04 | Why? |
| Immunoprecipitation | 1 | 2017 | 300 | 0.04 | Why? |
| Oligonucleotide Array Sequence Analysis | 1 | 2017 | 343 | 0.04 | Why? |
| Dependovirus | 1 | 2017 | 272 | 0.04 | Why? |
| Hospital Mortality | 1 | 2020 | 22087 | 0.04 | Why? |
| Biomarkers | 4 | 2020 | 23361 | 0.04 | Why? |
| Hyperlipidemias | 1 | 2018 | 290 | 0.04 | Why? |
| Amino Acid Motifs | 1 | 2017 | 620 | 0.04 | Why? |
| Dimerization | 1 | 2017 | 475 | 0.04 | Why? |
| Primates | 1 | 2018 | 584 | 0.04 | Why? |
| Nuclear Proteins | 1 | 2018 | 321 | 0.04 | Why? |
| Bone Marrow Transplantation | 1 | 2018 | 343 | 0.04 | Why? |
| Microscopy, Electron, Transmission | 1 | 2017 | 605 | 0.04 | Why? |
| Ubiquitin-Protein Ligases | 1 | 2017 | 249 | 0.04 | Why? |
| Statistics as Topic | 1 | 2017 | 370 | 0.04 | Why? |
| Transfection | 1 | 2017 | 864 | 0.03 | Why? |
| Longitudinal Studies | 2 | 2020 | 9893 | 0.03 | Why? |
| Carrier Proteins | 1 | 2018 | 513 | 0.03 | Why? |
| Lipid Metabolism | 1 | 2019 | 572 | 0.03 | Why? |
| MAP Kinase Signaling System | 1 | 2016 | 360 | 0.03 | Why? |
| DNA Methylation | 1 | 2019 | 688 | 0.03 | Why? |
| Fibrosis | 1 | 2017 | 800 | 0.03 | Why? |
| Alanine Transaminase | 1 | 2020 | 1329 | 0.03 | Why? |
| HEK293 Cells | 2 | 2017 | 8394 | 0.03 | Why? |
| Area Under Curve | 1 | 2021 | 2564 | 0.03 | Why? |
| Aspartate Aminotransferases | 1 | 2020 | 1394 | 0.03 | Why? |
| HeLa Cells | 1 | 2017 | 1303 | 0.03 | Why? |
| Phosphorylation | 1 | 2016 | 1060 | 0.03 | Why? |
| RNA, Small Interfering | 1 | 2017 | 817 | 0.03 | Why? |
| Recombinant Fusion Proteins | 1 | 2017 | 919 | 0.03 | Why? |
| Neoplasm Proteins | 1 | 2018 | 501 | 0.03 | Why? |
| Middle Aged | 9 | 2020 | 270681 | 0.03 | Why? |
| Antibodies | 1 | 2019 | 846 | 0.03 | Why? |
| Liver Function Tests | 1 | 2019 | 1325 | 0.03 | Why? |
| Retrospective Studies | 5 | 2020 | 105322 | 0.03 | Why? |
| Angiotensin II | 1 | 2017 | 601 | 0.03 | Why? |
| Female | 10 | 2020 | 380317 | 0.03 | Why? |
| Myocytes, Cardiac | 1 | 2017 | 804 | 0.03 | Why? |
| Antibodies, Neutralizing | 1 | 2018 | 25288 | 0.03 | Why? |
| Oceans and Seas | 1 | 2011 | 73 | 0.03 | Why? |
| Fermentation | 1 | 2011 | 156 | 0.03 | Why? |
| Coronary Disease | 1 | 2016 | 645 | 0.03 | Why? |
| Chemokines | 1 | 2017 | 1095 | 0.03 | Why? |
| Neoplasms | 1 | 2019 | 17251 | 0.03 | Why? |
| Cell Line, Tumor | 1 | 2019 | 3608 | 0.03 | Why? |
| Metabolic Syndrome | 1 | 2018 | 810 | 0.02 | Why? |
| Genetic Vectors | 1 | 2017 | 1600 | 0.02 | Why? |
| Multiple Organ Failure | 1 | 2020 | 1724 | 0.02 | Why? |
| Pandemics | 7 | 2020 | 389249 | 0.02 | Why? |
| Feasibility Studies | 1 | 2019 | 3467 | 0.02 | Why? |
| Hospitalization | 4 | 2021 | 54280 | 0.02 | Why? |
| Aged | 6 | 2020 | 215776 | 0.02 | Why? |
| ROC Curve | 1 | 2021 | 6024 | 0.02 | Why? |
| Mice, Inbred BALB C | 1 | 2019 | 5814 | 0.02 | Why? |
| Proportional Hazards Models | 1 | 2021 | 6543 | 0.02 | Why? |
| Apoptosis | 1 | 2017 | 2335 | 0.02 | Why? |
| Hypoglycemic Agents | 1 | 2020 | 2165 | 0.02 | Why? |
| Disease Susceptibility | 1 | 2020 | 4002 | 0.02 | Why? |
| Inflammation Mediators | 1 | 2018 | 2654 | 0.02 | Why? |
| Tumor Necrosis Factor-alpha | 1 | 2017 | 2483 | 0.02 | Why? |
| Oxidative Stress | 1 | 2017 | 2050 | 0.02 | Why? |
| Severity of Illness Index | 3 | 2021 | 48226 | 0.02 | Why? |
| Drug Therapy, Combination | 1 | 2020 | 7268 | 0.02 | Why? |
| Survival Rate | 1 | 2021 | 9206 | 0.02 | Why? |
| Kidney | 1 | 2020 | 3648 | 0.02 | Why? |
| Betacoronavirus | 5 | 2020 | 204454 | 0.02 | Why? |
| Myocardium | 1 | 2017 | 2323 | 0.02 | Why? |
| Magnetic Resonance Spectroscopy | 1 | 2011 | 881 | 0.02 | Why? |
| Predictive Value of Tests | 1 | 2020 | 9537 | 0.02 | Why? |
| Renin-Angiotensin System | 1 | 2020 | 3661 | 0.02 | Why? |
| Inpatients | 1 | 2020 | 5161 | 0.02 | Why? |
| Mortality | 1 | 2020 | 7132 | 0.02 | Why? |
| Treatment Outcome | 2 | 2021 | 51732 | 0.02 | Why? |
| Length of Stay | 1 | 2021 | 11042 | 0.02 | Why? |
| Magnetic Resonance Imaging | 1 | 2019 | 6551 | 0.01 | Why? |
| Polymerase Chain Reaction | 1 | 2017 | 6740 | 0.01 | Why? |
| Algorithms | 1 | 2019 | 7346 | 0.01 | Why? |
| Risk Factors | 2 | 2021 | 71621 | 0.01 | Why? |
| Research Design | 1 | 2018 | 5830 | 0.01 | Why? |
| Protein Binding | 1 | 2018 | 11430 | 0.01 | Why? |
| Ultrasonography | 1 | 2017 | 4409 | 0.01 | Why? |
| Disease Progression | 1 | 2019 | 13580 | 0.01 | Why? |
| Adult | 4 | 2020 | 244371 | 0.01 | Why? |
| Peptidyl-Dipeptidase A | 1 | 2020 | 9659 | 0.01 | Why? |
| Interleukin-6 | 1 | 2017 | 7522 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2019 | 22971 | 0.01 | Why? |
| Prevalence | 1 | 2019 | 25773 | 0.01 | Why? |
| Prognosis | 1 | 2020 | 32490 | 0.01 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2017 | 13720 | 0.01 | Why? |
| Italy | 1 | 2021 | 38444 | 0.01 | Why? |
| Adolescent | 2 | 2017 | 86841 | 0.01 | Why? |
| Young Adult | 2 | 2017 | 93724 | 0.01 | Why? |
| Comorbidity | 1 | 2020 | 34796 | 0.01 | Why? |
| Cytokines | 1 | 2017 | 15010 | 0.01 | Why? |